Debbie’s Story

Debbie was diagnosed with type 2 diabetes in her early 30s. She couldn’t get her blood sugar under control and was frustrated by having to take insulin shots in the middle of the day. When her doctor told her about V-Go, she was excited to learn there was a simpler and more convenient way to get her insulin that wouldn’t slow her down. By switching from multiple insulin shots to V-Go, she was able to significantly lower her A1c to 6.9.

Individual results may vary. All testimonials are truthful, however they may not reflect other users’ experiences and are not intended to represent or guarantee that anyone will achieve the same or similar results. Statements or claims made by third parties regarding the efficacy or functionality of V-Go as compared to other products are statements made by such individuals and should not be taken as evidence of clinical trial results supporting such statements or claims.

This page is sponsored by Zealand Pharma US, Inc. for the prescription medical device V-Go.

Important Risk Information

If regular adjustments or modifications to the basal rate of insulin are required in a 24-hour period, or if the amount of insulin used at meals requires adjustments of less than 2-Unit increments, use of the V-Go Wearable Insulin Delivery Device may result in hypoglycemia. The following conditions may occur during insulin therapy with V-Go: hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose). Other adverse reactions associated with V-Go use include skin irritation from the adhesive pad or infections at the infusion site. V-Go should be removed before any magnetic resonance imaging (MRI) testing.

Diabetes felt like a dark cloud over Debbie’s retirement at the lake

Important Risk Information